<p> Bharat Biotech International on Monday said that its BBV154 intranasal Covid vaccine has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.</p> <p> BBV154 is …
All Rights Reserved. India Narrative 2025